课题基金 / 基金详情

COVID-19: Data and Connectivity – National Core Study (D&C-NCS)

COVID-19: Data and Connectivity – National Core Study (D&C-NCS)
COVID-19:数据和连接 – 国家核心研究 (D
批准号:
MC_PC_20029
负责人:
Andrew Morris
金额:
$1048.67万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Andrew Morris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The COVID-19 Data and Connectivity National Core Study will build a national health data research capability to support priority COVID-19 research questions. It draws on lessons for health data research which have been learnt from COVID, showing how urgency and focus during the pandemic have enabled data to be used to generate insights that transformed our knowledge of COVID-19. These lessons highlighted significant challenges with data access, fragmentation, the importance of transparency and concerns over inherent inequalities and sustainability across approaches. The COVID-19 Data and Connectivity National Core Study will therefore ensure needed datasets are discoverable and accessible and linkages are established to answer the research questions prioritised by the five National Core Studies. These research questions and the supporting data and connectivity infrastructure will be critical in provisioning for the longer-term response to COVID. Delivery of the COVID-19 Data and Connectivity Study will involve close interaction with data custodians, the public and patients, and providers of UK-wide national Trusted Research Environments (TREs) to ensure the required data is stored safely and securely, made readily available to approved researchers and is associated with compute, analytical and data services that make it easier to address priority research questions in a transparent and trustworthy way.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12916-021-02000-w
发表时间: 2021-05-17
期刊: BMC medicine
影响因子: 9.3
作者: [Alsallakh MA, Sivakumaran S, Kennedy S, Vasileiou E, Lyons RA, Robertson C, Sheikh A, Davies GA, EAVE II Collaborators]
通讯作者: EAVE II Collaborators
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study
疫苗接种后 SARS-CoV-2 感染:基于社区的前瞻性、观察性病例对照研究中的危险因素和疾病概况
DOI: 10.1101/2021.05.24.21257738
发表时间: 2021
期刊:
影响因子: --
作者: [Antonelli M]
通讯作者: Antonelli M
DOI: 10.1016/j.vaccine.2023.01.023
发表时间: 2023-02-10
期刊: VACCINE
影响因子: 5.5
作者: [Bedston, Stuart, Lowthian, Emily, Jarvis, Christopher I, Akbari, Ashley, Beggs, Jillian, Bradley, Declan, de Lusignan, Simon, Griffiths, Rowena, Herbert, Laura, Hobbs, Richard, Kerr, Steven, Lyons, Jane, Midgley, William, Owen, Rhiannon K, Quint, Jennifer K, Tsang, Ruby, Torabi, Fatemeh, Sheikh, Aziz, Lyons, Ronan A]
通讯作者: Lyons, Ronan A
DOI: 10.18632/aging.205058
发表时间: 2023-09-25
期刊: AGING-US
影响因子: 5.2
作者: [Beydoun, May A., Beydoun, Hind A., Fanelli-Kuczmarski, Marie T., Weiss, Jordan, Georgescu, Michael F., Meirelles, Osorio, Lyall, Donald M., Evans, Michele K., Zonderman, Alan B.]
通讯作者: Zonderman, Alan B.
7
    Harnessing the power of diverse populations to empower clinical translation of genome-wide association studies of common human disease
    • 批准号:
      MR/W029626/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $53.16万
    • 财政年份:
      2023
    • 负责人:
      Andrew Morris
    • 依托单位:
    Novel statistical methods for transcriptomic imputation to enhance understanding of causal mechanisms underlying human diseases
    • 批准号:
      MR/V020749/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $57.45万
    • 财政年份:
      2022
    • 负责人:
      Andrew Morris
    • 依托单位:
    UKRI trusted and connected Data and Analytics Research Environments, Phase 1
    • 批准号:
      MC_PC_21005
    • 项目类别:
      Intramural
    • 资助金额:
      $370.25万
    • 财政年份:
      2021
    • 负责人:
      Andrew Morris
    • 依托单位:
    Population Research UK Phase 1: Partnership Design & Dialogue
    • 批准号:
      MC_PC_20024
    • 项目类别:
      Intramural
    • 资助金额:
      $76.45万
    • 财政年份:
      2021
    • 负责人:
      Andrew Morris
    • 依托单位:
    国内基金
    海外基金
    芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
    1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
    ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
    • 批准号:
      2026JJ80001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      钟根深
    • 依托单位:
    CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
    • 批准号:
      2026JJ81339
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢希
    • 依托单位: